Abstract:The tumor suppressor activity of PTEN (phosphatase and tensin homolog deleted on chromosome 10) is thought to be largely attributable to its lipid phosphatase activity. PTEN dephosphorylates the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate to directly antagonize the phosphoinositide 3-kinase-Akt pathway and prevent the activating phosphorylation of Akt. PTEN has also other proposed mechanisms of action, including a poorly characterized protein phosphatase activity, protein–protein interactions, as well as emerging functions in different compartment of the cells such as nucleus and mitochondria. We show here that a fraction of PTEN protein localizes to the endoplasmic reticulum (ER) and mitochondria-associated membranes (MAMs), signaling domains involved in calcium (2+) transfer from the ER to mitochondria and apoptosis induction. We demonstrate that PTEN silencing impairs ER Ca2+ release, lowers cytosolic and mitochondrial Ca2+ transients and decreases cellular sensitivity to Ca2+-mediated apoptotic stimulation. Specific targeting of PTEN to the ER is sufficient to enhance ER-to-mitochondria Ca2+ transfer and sensitivity to apoptosis. PTEN localization at the ER is further increased during Ca2+-dependent apoptosis induction. Importantly, PTEN interacts with the inositol 1,4,5-trisphosphate receptors (IP3Rs) and this correlates with the reduction in their phosphorylation and increased Ca2+ release. We propose that ER-localized PTEN regulates Ca2+ release from the ER in a protein phosphatase-dependent manner that counteracts Akt-mediated reduction in Ca2+ release via IP3Rs. These findings provide new insights into the mechanisms and the extent of PTEN tumor-suppressive functions, highlighting new potential strategies for therapeutic intervention.

Astrocytic phosphatase and tensin homolog deleted on chromosome 10 regulates neuropathic pain by facilitating 3-hydroxy-3-methylglutaryl-CoA reductase–dependent cholesterol biosynthesis

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Phosphatase and tension homology deleted from chromosome ten and tumor

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

Regulation of Phosphatase and Tensin Homology Deleted on Chromosome 10

Function of Phosphatase and Tensin Homologue Deleted on Chromosome 10 in Formation and Maintenance of Neuronal Circuits in Brain

Phosphatase and Tensin Homology Deleted on Chromosome 10 and Neural Development

Decoding PTEN: from biological functions to signaling pathways in tumors

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

New Insights into PTEN Regulation Mechanisms and Its Potential Function in Targeted Therapies.

Pten Acetylation Modulates Its Interaction With Pdz Domain

Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Regulatory Mechanisms of PTEN

Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner

PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression

PTEN, a General Negative Regulator of Cyclin D Expression

Targeting PTEN Regulation by Post Translational Modifications

The Protein Phosphatase Activity of PTEN is Essential for Regulating Neural Stem Cell Differentiation

Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor

PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning.